M&A · Healthcare · Electromedical & Electrotherapeutic Apparatus
ArchiMed Group to acquire Natus Medical Inc
Announced Apr 18, 2022 · Closed Jul 21, 2022
Deal value$1.20BEV $1.16B
Premium29.0%To unaffected price
EV / Adj. EBITDA15.3x2.5x EV / Revenue
ConsiderationAll cash$33.50 per share
Transaction
- Acquirer
- ArchiMed Group
- Target
- Natus Medical Inc
- Buyer type
- Private equity
- Offer price per share
- $33.50
- Enterprise value
- $1.16B
- Status
- Closed Jul 21, 2022
Deal protections
- Break fee (target pays)
- —
- Reverse fee (buyer pays)
- —
- Go-shop
- Go-shop
- Financing
- Committed · Jefferies
Advisors
- To the acquirer
- Jefferies
- To the target
- Stifel
Sector context · Healthcare
- Comparable deals
- 41 in the prior 24 months
- Premium
- 29.0% vs. 45.5% sector median
- EV / Adj. EBITDA
- 15.3x vs. 20.4x sector median
- Break fee
- Sector median 3.4%
Timeline
- AnnouncedApr 18, 2022
- Proxy filedMay 23, 2022
- Definitive proxyJun 2, 2022
- Shareholder voteJul 6, 2022
- ClosedJul 21, 2022
Valuation · fairness opinions
Discounted cash flow$24.00$36.00
Offer $33.50
Implied value per Natus Medical Inc share by analysis, from Stifel · DCF discount rate 10%–12%.